Skip to main content

Table 1 PKD2 variants in 21 ADPKD2 patients

From: TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes

Patient number

Family ID

Mutation (cDNA)

Protein change

TRPP2 expression (ADPKD2/controls)

Dialysis (age)

Hypertension

Extra-renal manifestations

Pathogenicity of PKD2 mutation

90

PKD2MO65

8293C > T and 10043G > A in PKD1; IVS4 + 1G > A in PKD2

In PC1: Arg2765Cys and Arg3348Gln. In TRPP2: Ala365fs

0.74

no

no

none

definitely pathogenic

91

PKD2MO50

2614C > T

Arg872X

0.55

no

yes

Pancreatic and liver cysts

definitely pathogenic

92

PKD2MO50

2614C > T

Arg872X

0.78

no

yes

mitral prolapse

definitely pathogenic

93

PKD2MO50

2614C > T

Arg872X

0.31

yes (72)

yes

none

definitely pathogenic

94

PKD2MO50

2614C > T

Arg872X

0.7

no

no

none

definitely pathogenic

95

PKD2MO87

ivs3 + 1G > T

Phe282fs

0.86

yes (59)

yes

polycystic liver, diverticulosis of colon

definitely pathogenic

96

PKD2MO87

ivs3 + 1G > T

Phe282fs

0.43

yes (50)

yes

polycystic liver

definitely pathogenic

97

PKD2MO87

ivs3 + 1G > T

Phe282fs

0.51

no

yes

none

definitely pathogenic

98

PKD2MO87

ivs3 + 1G > T

Phe282fs

NA

yes (62)

yes

none

definitely pathogenic

99

PKD2MO87

ivs3 + 1G > T

Phe282fs

NA

yes (60)

yes

polycystic liver

definitely pathogenic

100

PKD2MO21

ivs5 + 5G > A, ivs9 2020-2089_86del

unknown

NA

no

yes

polycystic liver

unknown

101

PKD2MO21

ivs5 + 5G > A, ivs9 2020-2089_86del

unknown

NA

no

yes

none

unknown

102

PKD2MO21

ivs5 + 5G > A, ivs9 2020-2089_86del

unknown

NA

no

yes

none

unknown

103

PKD2MO29

1158 T > A

Tyr386X

0.39

no

no

polycystic liver

definitely pathogenic

104

PKD2FE15

1158 T > A

Tyr386X

0.47

yes (67)

yes

none

definitely pathogenic

105

PKD2FE15

1158 T > A

Tyr386X

0.31

no

yes

none

definitely pathogenic

106

PKD2FE15

1158 T > A

Tyr386X

0.55

yes (55)

no

cerebral aneurism

definitely pathogenic

107

PKD2FE15

1158 T > A

Tyr386X

0.39

yes (69)

no

none

definitely pathogenic

108

PKD2FE5

858delC

Ser286fs30X

0.27

yes (82)

no

myocardiosclerosis

definitely pathogenic

109

PKD2FE5

858delC

Ser286fs30X

0.35

yes (73)

no

obstructive vascular disease

definitely pathogenic

110

PKD2FE5

858delC

Ser286fs30X

0.39

yes (66)

no

polycystic liver, myocardiosclerosis and cerebral ictus

definitely pathogenic

  1. ADPKD2 patient numbering is referred to Additional file 1: Table S1
  2. The age of ADPKD2 patients is ranging from 26 to 89 years. TRPP2 expression and clinical parameters are indicated. Values of TRPP2 were calculated as ratio between the levels of TRPP2 in ADPKD2 patients and healthy controls